These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 2011974

  • 1. [The evaluation of the effect of Estracyt on prostatic cancer].
    Fukuoka H, Ishibashi Y, Sakai N, Ogawa T, Satomi Y, Sugawara T, Kamimura H, Yamaguchi T, Kishida K, Shirai K.
    Hinyokika Kiyo; 1991 Jan; 37(1):91-7. PubMed ID: 2011974
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study of estramustine phosphate disodium (Estracyt) on prostatic cancer--results of long-term therapy for 38 patients with prostatic cancer].
    Asakawa M, Wada S, Hayahara N, Yayumoto R, Kishimoto T, Maekawa M, Morikawa Y, Kawakita J, Umeda M, Horii A.
    Hinyokika Kiyo; 1990 Nov; 36(11):1361-9. PubMed ID: 2288316
    [Abstract] [Full Text] [Related]

  • 3. [The phase IV studies with Estracyt in prostatic cancer].
    Ohhori T, Kubo T, Akasaka T, Funyu T, Yagihashi Y, Kudo T, Tsuchida S, Harada T, Sasaki S, Orikasa S.
    Hinyokika Kiyo; 1988 Aug; 34(8):1493-502. PubMed ID: 3057833
    [Abstract] [Full Text] [Related]

  • 4. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 5. [The phase IV studies with Estracyt in prostatic cancer--supplementary report: results of long-term therapy].
    Ohhori T, Kubo T, Kawamura S, Suzuki T, Yagihashi Y, Kudo T, Tsuchida S, Harada T, Sasaki S, Orikasa S.
    Hinyokika Kiyo; 1992 Aug; 38(8):979-87. PubMed ID: 1414749
    [Abstract] [Full Text] [Related]

  • 6. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A, Morvay J, Vécsei B.
    Orv Hetil; 1981 Apr 26; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract] [Full Text] [Related]

  • 7. Effect of estramustine phosphate on free androgens. A comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer.
    Van Poppel H, Werbrouck PW, Baert L.
    Acta Urol Belg; 1990 Apr 26; 58(4):89-95. PubMed ID: 2093302
    [Abstract] [Full Text] [Related]

  • 8. Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.
    Mackler NJ, Dunn RL, Hellerstedt B, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC.
    Cancer; 2006 Jun 15; 106(12):2617-23. PubMed ID: 16691618
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H, Shida K.
    Gan To Kagaku Ryoho; 1984 Mar 15; 11(3):537-44. PubMed ID: 6422861
    [Abstract] [Full Text] [Related]

  • 10. Administration of estramustine in response to changes in the prostate-specific antigen and Karnofsky index in the treatment of prostate cancer.
    Pintér O, Molnár J, Tóth C, Szabó Z, Lipták J, Fél P, Papp G, Hollman E, Hazay L, Streit B, Kisbenedek L, Fehér M, Kocsis I, Pajor L.
    In Vivo; 2005 Mar 15; 19(4):787-92. PubMed ID: 15999550
    [Abstract] [Full Text] [Related]

  • 11. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ, Morales A.
    Can J Surg; 1983 Sep 15; 26(5):434-8. PubMed ID: 6351988
    [Abstract] [Full Text] [Related]

  • 12. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J, Jung JL, Bittard M.
    J Urol (Paris); 1984 Sep 15; 90(1):27-33. PubMed ID: 6725973
    [Abstract] [Full Text] [Related]

  • 13. Oral estramustine therapy in serum chromogranin A-positive stage D3 prostate cancer patients.
    Zaky Ahel M, Kovacic K, Kraljic I, Tarle M.
    Anticancer Res; 2001 Sep 15; 21(2B):1475-9. PubMed ID: 11396235
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M.
    Actas Urol Esp; 1984 Sep 15; 8(5):399-402. PubMed ID: 6524487
    [No Abstract] [Full Text] [Related]

  • 15. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E.
    Gan To Kagaku Ryoho; 1984 Oct 15; 11(10):2106-14. PubMed ID: 6486830
    [Abstract] [Full Text] [Related]

  • 16. Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Greco FA, Morrissey LH, Raefsky EL, Steis RG, Butts JA, Hainsworth JD, Minnie Pearl Cancer Research Network.
    Cancer; 2003 Nov 15; 98(10):2192-8. PubMed ID: 14601089
    [Abstract] [Full Text] [Related]

  • 17. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Fritjofsson A, Norlén BJ, Högberg B, Rajalakshmi M, Cekan SZ, Diczfalusy E.
    Scand J Urol Nephrol; 1981 Nov 15; 15(1):37-44. PubMed ID: 6787701
    [Abstract] [Full Text] [Related]

  • 18. Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
    Berruti A, Fara E, Tucci M, Tarabuzzi R, Mosca A, Terrone C, Gorzegno G, Fasolis G, Tampellini M, Porpiglia F, De Stefanis M, Fontana D, Bertetto O, Dogliotti L, Gruppo Onco-Urologico Piemontese, Rete Oncologica Piemontese.
    Urol Oncol; 2005 Nov 15; 23(1):1-7. PubMed ID: 15885575
    [Abstract] [Full Text] [Related]

  • 19. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I.
    Orv Hetil; 1982 Jan 31; 123(5):287-9. PubMed ID: 7063244
    [No Abstract] [Full Text] [Related]

  • 20. [Stage D1 prostatic cancer benefited by a single regimen of Estracyt].
    Hata M.
    Gan To Kagaku Ryoho; 1988 May 31; 15(5):1787-90. PubMed ID: 3369873
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.